Wherein we ponder vexing issues in infection prevention and control, inside and outside the hospital.
Tuesday, September 14, 2010
NDM-1 in the US (Boston, California and Illinois)
MGH - where one NDM-1 patient was treated
Out of ICAAC there is a report of three carbapenem-resistant (NDM-1) cases in the US, all of whom had medical care in India prior to travelling to the US. Per a Tribune article, "the three U.S. cases involved three different bacteria that remain susceptible to at least one of three antibiotics: colistin, polymixin and tigecycline, said Karen Bush, an Indiana University professor..." If you'll notice, the reports all call NDM-1 a 'superbug.' I find this funny since NDM-1 isn't even a bacteria but a gene that can be found in several pathogens, as described in this ICAAC report. Anyway, gotta feel bad for MRSA. Just when it let its guard down, this new guy just takes over. Kinda like what Nadal has done to Federer.